C Wurthmann, E Klieser, E Lehmann
Index: Fortschr. Neurol. Psychiatr. 63(2) , 72-7, (1995)
Full Text: HTML
The present study was designed to investigate the interaction between therapeutic effects and side-effects in fluspirilene treatment of generalised anxiety disorders (GAD). 205 outpatients received in an open trial 1.5 mg fluspirilene per week for 6 weeks. Confirming previous reports of our study group fluspirilene demonstrated marked efficacy and was generally well tolerated. However, the main finding of our study is that side effects, although rare in fluspirilene treatment, predict an unfavourable clinical outcome. This phenomenon is integrated in a psychological model implying that when GAD patients are aware of side-effects this induces anxiety. Again anxiety gives rise to somatic symptoms, both interacting in a forward loop. In conclusion, our data suggest that in the sense of Heinrich (1988) fluspirilene treatment of GAD should be guided by paying attention to possible side effects.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
fluspirilene
CAS:1841-19-6 |
C29H31F2N3O |
Small molecule regulators of autophagy identified by an imag...
2007-11-27 [Proc. Natl. Acad. Sci. U. S. A. 104 , 19023-8, (2007)] |
Determination of fluspirilene in human plasma by liquid chro...
1998-12-18 [J. Chromatogr. A. 828(1-2) , 219-27, (1998)] |
Test therapy in the treatment of generalized anxiety disorde...
1995-10-01 [Prog. Neuropsychopharmacol. Biol. Psychiatry 19(6) , 1049-60, (1995)] |
A crystallographic and molecular modeling study of butyrophe...
1998-12-01 [J. Pharm. Sci. 87(12) , 1496-501, (1998)] |
Grief hallucinations: true or pseudo? Serious or not? An inq...
2002-01-01 [Psychopathology 35(5) , 296-302, (2002)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved